Table 3.
Patient Characteristics at Baseline in the SFMIH Cohort
| SFMIH (n = 467) | Mutated (n = 34) | Not Mutated (n = 433) | Chi-Squared Test | |
|---|---|---|---|---|
| Age | ||||
| median | 54.5 | 56 | ns | |
| IQR | 51–59.5 | 49–61 | ||
| Grade | ns | |||
| 1 | 19 (55.88) | 302 (69.75) | ||
| 2 | 6 (17.65) | 52 (12.01) | ||
| 3 | 7 (20.59) | 56 (12.93) | ||
| Mixed | 2 (5.88) | 11 (2.54) | ||
| Clinical stage | ns | |||
| I | 25 (73.53) | 363 (83.83) | ||
| II | 5 (14.71) | 32 (7.39) | ||
| III | 4 (11.76) | 34 (7.85) | ||
| IV | 0 (0.00) | 4 (0.92) | ||
| Histology | ns | |||
| Endometrioid | 27 (79.41) | 371 (85.68) | ||
| Serous | 4 (11.76) | 30 (6.93) | ||
| Mixed | 1 (2.94) | 6 (1.39) | ||
| Clear | 0 (0.00) | 1 (0.23) | ||
| Carcinosarcoma | 1 (2.94) | 12 (2.77) | ||
| Undifferentiated | 1 (2.94) | 13 (3.00) |